Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors (CGMs ... In March 2024, a jury found that Dexcom’s G6 glucose monitors infringed one of three of Abbott’s patents, ...

In a report released yesterday, William Plovanic from Canaccord Genuity maintained a Buy rating on Dexcom (DXCM – Research Report), with a ...

Acton, Massachusetts-based Insulet touts Omnipod 5 as the number one insulin pump for new users in Europe. It remains the top ...

Dexcom (DXCM) has received a new Buy rating, initiated by Wells Fargo analyst, Larry Biegelsen.Stay Ahead of the Market:Discover outperforming ...

Dec 23 (Reuters) - Abbott Laboratories (ABT.N), opens new tab and DexCom (DXCM.O), opens ... patent disputes between them related to continuous glucose monitoring devices. The agreement will ...

Bengaluru: Abbott Laboratories and DexCom said on Monday they have reached an agreement to settle all patent disputes between them related to continuous glucose monitoring devices. The agreement ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its ...

Dexcom is a developer and marketer of continuous glucose monitoring ... Its top products include the Dexcom G6 which provides real-time glucose monitoring, Dexcom G7 which is user-friendly ...

Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI ...

and a continuous glucose monitor (CGM) has been instrumental in achieving that. Unless you’re an advocate for health tech or a diabetic like me, you may not have heard of Dexcom or Abbott ...